हाल में देखा गया

  • होम
  • स्टोरी
  • News Announcement
  • Aspira Pathlab & Diagnostics: Board Meeting Intimation for Approval Of Un-Audited Financial Result (Standalone) For The First Quarter Ended On June 30 2026 And To Transact Other Businesses
News Announcement

Aspira Pathlab & Diagnostics: Board Meeting Intimation for Approval Of Un-Audited Financial Result (Standalone) For The First Quarter Ended On June 30 2026 And To Transact Other Businesses

06-अगस्त-2026 Follow Value Research Online on Google download pdfडाउनलोड पीडीएफ़ Aspira Pathlab

Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve 1.Unaudited Financial Result(Standalone) along with Limited Review Report for the First Quarter ended June 30 2026 To consider evaluate and if deem fit to approve the proposal for raising of funds by way of issuance via various mode and to transact Other Businesses.

वैल्यू रिसर्च से पूछें aks value research information

कोई सवाल छोटा नहीं होता. पर्सनल फ़ाइनांस, म्यूचुअल फ़ंड्स, या फिर स्टॉक्स पर बेझिझक अपने सवाल पूछिए, और हम आसान भाषा में आपको जवाब देंगे.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan